IL6 and inflammatory bowel disease: Pro-inflammatory signaling molecules, including interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6), are notably elevated in both IBD and atherosclerosis [31-33].